Screening for Breast Cancer in Men Has Increased Over Time
Screening for breast cancer in men has increased over time, with high sensitivity and specificity for mammographic screening.
Breast Cancer
FDA Warns of Possible Interstitial Lung Disease, Pneumonitis With Certain Breast Cancer Drugs
Healthcare professionals are being advised to monitor patients regularly for pulmonary symptoms indicative of ILD and/or pneumonitis, including hypoxia, cough, dyspnea, and interstitial infiltrates on radiologic exams.
Implant-Associated Cancers: A Look Beyond BIA-ALCL
Recent and upcoming case reports suggest possible cases of gluteal and other implant-associated ALCLs, raising questions about the cancer risk across all types of implants.
Full Chemo Doses May Improve Survival in Breast Cancer
Maintaining full doses of chemo especially important early in the treatment course.
Mammos May Not Benefit Elderly Women With Chronic Illness
Risk for death from other causes much higher than risk for breast cancer death with increasing comorbidity, age.
USPSTF Advises Meds to Reduce Risk for Primary Breast Cancer
Offer risk-reducing meds to women at higher risk for breast cancer, low risk for adverse medication effects.
Germline Testing Should Be Routinely Conducted in Patients With Metastatic Breast Cancer
High prevalence of pathogenic/likely pathogenic variants supports wider testing.
Type and Timing of Menopausal HRT Affect Risk for Breast Cancer
Some excess risk persists for >10 years after ceasing therapy; magnitude varies with duration of use.
Knowing the Appropriateness of Running Noninferiority Trials in Oncology
Researches took a critical look at noninferiority trials and determined that when a new intervention is “not worse,” the possibility exists that it is not better, either.
Does Radioactive Iodine Treatment for Hyperthyroidism Confer A Higher Cancer Risk?
Over the past decade, researchers have found inconsistent evidence about whether radioactive iodine treatment for hyperthyroidism can cause cancer in the long term.
